KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Change in Intangibles (2022 - 2024)

Eli Lilly (LLY) has disclosed Change in Intangibles for 8 consecutive years, with $70.1 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Change in Intangibles rose 23466.67% year-over-year to $70.1 million, compared with a TTM value of $599.8 million through Dec 2024, up 13.21%, and an annual FY2025 reading of $218.0 million, down 63.73% over the prior year.
  • Change in Intangibles was $70.1 million for Q4 2024 at Eli Lilly, up from -$300000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $500.0 million in Q2 2023 and bottomed at -$300000.0 in Q4 2023.
  • Average Change in Intangibles over 3 years is $150.0 million, with a median of $50.0 million recorded in 2022.
  • The sharpest move saw Change in Intangibles tumbled 101.0% in 2023, then skyrocketed 23466.67% in 2024.
  • Year by year, Change in Intangibles stood at $30.0 million in 2022, then plummeted by 101.0% to -$300000.0 in 2023, then surged by 23466.67% to $70.1 million in 2024.
  • Business Quant data shows Change in Intangibles for LLY at $70.1 million in Q4 2024, -$300000.0 in Q4 2023, and $500.0 million in Q2 2023.